EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRW and the CUSIP is G3141W122. A total of 28 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $970 | -35.9% | 26,838 | -1.4% | 0.00% | – |
Q4 2022 | $1,513 | +51.3% | 27,218 | +1.5% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 26,813 | -3.1% | 0.00% | – |
Q2 2022 | $2,000 | -60.0% | 27,670 | +4.0% | 0.00% | – |
Q1 2022 | $5,000 | -66.7% | 26,611 | +0.0% | 0.00% | – |
Q4 2021 | $15,000 | -21.1% | 26,600 | -0.2% | 0.00% | – |
Q3 2021 | $19,000 | -32.1% | 26,640 | +0.2% | 0.00% | – |
Q2 2021 | $28,000 | -15.2% | 26,600 | 0.0% | 0.00% | – |
Q1 2021 | $33,000 | – | 26,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 66,666 | $668,000 | 0.02% |
Radcliffe Capital Management, L.P. | 33,333 | $334,000 | 0.01% |
Arena Investors LP | 94,516 | $3,719,000 | 0.00% |
Altium Capital Management LP | 133,333 | $5,000 | 0.00% |
Granite Point Capital Management, L.P. | 133,332 | $5,000 | 0.00% |
683 Capital Management, LLC | 200,000 | $8,000 | 0.00% |
JANE STREET GROUP, LLC | 26,813 | $1,000 | 0.00% |
PRICE T ROWE ASSOCIATES INC /MD/ | 22,697 | $1,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 159,433 | $4 | 0.00% |
PERISCOPE CAPITAL INC. | 15,300 | $1,000 | 0.00% |